1 Service de Réanimation Médico-Chirurgicale, Hôpital Louis Mourier, Assistance Publique-Hôpitaux de Paris (AP-HP), Colombes, France.
2 Unité Mixte de Recherche (UMR) S1155, Remodeling and Repair of Renal Tissue, Hôpital Tenon, French National Institute of Health and Medical Research (INSERM), Paris, France.
Am J Respir Crit Care Med. 2018 Jul 1;198(1):58-66. doi: 10.1164/rccm.201706-1255OC.
The optimal strategy for initiation of renal replacement therapy (RRT) in patients with severe acute kidney injury in the context of septic shock and acute respiratory distress syndrome (ARDS) is unknown.
To examine the effect of an early compared with a delayed RRT initiation strategy on 60-day mortality according to baseline sepsis status, ARDS status, and severity.
Post hoc analysis of the AKIKI (Artificial Kidney Initiation in Kidney Injury) trial.
Subgroups were defined according to baseline characteristics: sepsis status (Sepsis-3 definition), ARDS status (Berlin definition), Simplified Acute Physiology Score 3 (SAPS 3), and Sepsis-related Organ Failure Assessment (SOFA). Of 619 patients, 348 (56%) had septic shock and 207 (33%) had ARDS. We found no significant influence of the baseline sepsis status (P = 0.28), baseline ARDS status (P = 0.94), and baseline severity scores (P = 0.77 and P = 0.46 for SAPS 3 and SOFA, respectively) on the comparison of 60-day mortality according to RRT initiation strategy. A delayed RRT initiation strategy allowed 45% of patients with septic shock and 46% of patients with ARDS to escape RRT. Urine output was higher in the delayed group. Renal function recovery occurred earlier with the delayed RRT strategy in patients with septic shock or ARDS (P < 0.001 and P = 0.003, respectively). Time to successful extubation in patients with ARDS was not affected by RRT strategy (P = 0.43).
Early RRT initiation strategy was not associated with any improvement of 60-day mortality in patients with severe acute kidney injury and septic shock or ARDS. Unnecessary and potentially risky procedures might often be avoided in these fragile populations. Clinical trial registered with www.clinicaltrials.gov (NCT 01932190).
在感染性休克和急性呼吸窘迫综合征(ARDS)背景下发生严重急性肾损伤的患者,开始肾脏替代治疗(RRT)的最佳策略尚不清楚。
比较早期与延迟 RRT 起始策略对根据基线脓毒症状态、ARDS 状态和严重程度的 60 天死亡率的影响。
AKIKI(肾损伤中人工肾的启动)试验的事后分析。
根据基线特征定义亚组:脓毒症状态(Sepsis-3 定义)、ARDS 状态(柏林定义)、简化急性生理学评分 3(SAPS 3)和脓毒症相关器官衰竭评估(SOFA)。在 619 例患者中,348 例(56%)有感染性休克,207 例(33%)有 ARDS。我们发现基线脓毒症状态(P=0.28)、基线 ARDS 状态(P=0.94)和基线严重程度评分(分别为 SAPS 3 和 SOFA,P=0.77 和 P=0.46)对 RRT 起始策略的 60 天死亡率无显著影响。延迟 RRT 起始策略使 45%的感染性休克患者和 46%的 ARDS 患者避免了 RRT。延迟组的尿量较高。延迟 RRT 策略使感染性休克或 ARDS 患者的肾功能恢复更早(P<0.001 和 P=0.003)。ARDS 患者的成功脱机时间不受 RRT 策略的影响(P=0.43)。
在严重急性肾损伤伴感染性休克或 ARDS 的患者中,早期 RRT 起始策略与 60 天死亡率的改善无关。在这些脆弱人群中,常常可以避免不必要和潜在危险的程序。该临床试验已在 www.clinicaltrials.gov(NCT 01932190)注册。